Events

Immune tolerance offers a transformative approach to autoimmune diseases treatment and holds the power to modify the course of disease progression and significantly improve the...

Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering as the best place to allocate their money and resources...

With RNA technologies receiving the Nobel Prize two years running, we are witnessing the mRNA industry make great strides as optimized analytics, critical quality control methodology...

Standard Operating Procedures (SOPs) are the basis for a large part of the day-to-day training that most pharmaceutical employees are required to perform. Still, it is not widely...

As the cell and gene therapy (CGT) pipeline matures and new, exciting technologies scale into the clinic, the success of delivering the growing number of complex CGTs to patients...

Please contact Email - [email protected] or Call - +91 44 24762472 / M: +91 9361957193 DELEGATE REGISTRATION:Super Early Bird Price (Valid until 28th Jan 2025) &ndash...

Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two...

In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis...

Join us in March for an exciting three-day exploration into the future of medicines manufacturing research and innovation! CMAC, a medicines manufacturing research centre located...

Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like Quell and AstraZeneca, and...

Welcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene therapy approvals in the last 18 months...

The field of conjugatable drugs is advancing at a rapid pace, with major collaborations like Nurix and Pfizer for antibody-degrader conjugates and Bicycle and Novartis for radiopharmace...

2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Immatics, Triumvira, Affini-T,...

With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whether for nose-to-brain delivery...

Food and drug oversight, Pivotal events that shaped laws in US and scope of FDA actions, GMP vs. cGMP, Consequences of noncompliance, Avoiding over-reliance on metrics, Recent...